Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of the Oncology Opportunity Cost Assessment Tool (OOCAT)

NCT04694911 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT04694911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04694911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of the Oncology Opportunity Cost Assessment Tool (OOCAT)
Lead sponsor
Thomas Jefferson University
Phase
Observational
Overall status
Completed
Start date
November 21, 2019
Completion date
July 31, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm